Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24580

1.

Correction: Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing.

Ozgyin L, Horvath A, Balint BL.

Oncotarget. 2018 Nov 9;9(88):35872. doi: 10.18632/oncotarget.26361. eCollection 2018 Nov 9.

2.

Correction: Molecular response prediction in CML: novel ideas?

Wolf D, Sopper S.

Oncotarget. 2018 Nov 9;9(88):35871. doi: 10.18632/oncotarget.26360. eCollection 2018 Nov 9.

3.

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.

Bjoern J, Lyngaa R, Andersen R, Hölmich LR, Hadrup SR, Donia M, Svane IM.

Oncotarget. 2018 Nov 9;9(88):35870. doi: 10.18632/oncotarget.26359. eCollection 2018 Nov 9.

4.

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions.

Marshall VA, Labo N, Sztuba-Solinska J, Castro EMC, Aleman K, Wyvill KM, McNamara L, Le Grice SFJ, Yarchoan R, Uldrick TS, MacPhail P, Polizzotto MN, Whitby D.

Oncotarget. 2018 Nov 9;9(88):35856-35869. doi: 10.18632/oncotarget.26321. eCollection 2018 Nov 9.

5.

MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs.

Okamoto K, Ohishi T, Kuroiwa M, Iemura SI, Natsume T, Seimiya H.

Oncotarget. 2018 Nov 9;9(88):35844-35855. doi: 10.18632/oncotarget.26312. eCollection 2018 Nov 9.

6.

Serum starvation raises turnover of phosphorylated p62/SQSTM1 (Serine 349), reveals expression of proteasome and N-glycanase1 interactive protein RAD23B and sensitizes human synovial fibroblasts to BAY 11-7085-induced cell death.

Relic B, Charlier E, Deroyer C, Malaise O, Crine Y, Neuville S, Gillet P, de Seny D, Malaise MG.

Oncotarget. 2018 Nov 9;9(88):35830-35843. doi: 10.18632/oncotarget.26295. eCollection 2018 Nov 9.

7.

Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells.

Argenziano M, Lombardi C, Ferrara B, Trotta F, Caldera F, Blangetti M, Koltai H, Kapulnik Y, Yarden R, Gigliotti L, Dianzani U, Dianzani C, Prandi C, Cavalli R.

Oncotarget. 2018 Nov 9;9(88):35813-35829. doi: 10.18632/oncotarget.26287. eCollection 2018 Nov 9.

8.

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors.

Sigal DS, Bhangoo MS, Hermel JA, Pavlick DC, Frampton G, Miller VA, Ross JS, Ali SM.

Oncotarget. 2018 Nov 9;9(88):35809-35812. doi: 10.18632/oncotarget.26260. eCollection 2018 Nov 9.

9.

Modulation of PI3K signaling to improve CAR T cell function.

Zheng W, Jones LL, Geiger TL.

Oncotarget. 2018 Nov 9;9(88):35807-35808. doi: 10.18632/oncotarget.26334. eCollection 2018 Nov 9. No abstract available.

10.

The riddle of lymphoma BCR-antigenes.

Thurner L, Hartmann S, Preuss KD, Bewarder M.

Oncotarget. 2018 Nov 9;9(88):35805-35806. doi: 10.18632/oncotarget.26318. eCollection 2018 Nov 9. No abstract available.

11.

Inducing rapid telomere irreparable damage in telomerase-expressing cancers.

Zhang G, Shay JW.

Oncotarget. 2018 Nov 9;9(88):35803-35804. doi: 10.18632/oncotarget.26317. eCollection 2018 Nov 9. No abstract available.

12.

Multiple mechanisms can disrupt oncogenic pathways in multiple myeloma.

Hoang PH, Houlston RS.

Oncotarget. 2018 Nov 9;9(88):35801-35802. doi: 10.18632/oncotarget.26301. eCollection 2018 Nov 9. No abstract available.

13.

LIGHT/BTLA polymorphisms and antibody-mediated-rejection after heart transplantation.

Marrón-Liñares GM, Núñez L, Hermida-Prieto M.

Oncotarget. 2018 Nov 9;9(88):35799-35800. doi: 10.18632/oncotarget.26327. eCollection 2018 Nov 9. No abstract available.

14.

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer.

Antonarakis ES.

Oncotarget. 2018 Nov 9;9(88):35797-35798. doi: 10.18632/oncotarget.26296. eCollection 2018 Nov 9. No abstract available.

15.

Correction: The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma.

Pagès G.

Oncotarget. 2018 Nov 6;9(87):35796. doi: 10.18632/oncotarget.26340. eCollection 2018 Nov 6.

16.

Correction: Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures.

Dekky B, Ruff M, Bonnier D, Legagneux V, Théret N.

Oncotarget. 2018 Nov 6;9(87):35795. doi: 10.18632/oncotarget.26339. eCollection 2018 Nov 6.

17.

Attaining threshold antibody cytotoxicity for selective tumor cell destruction: an opinion article.

Seledtsov VI, Seledtsova GV.

Oncotarget. 2018 Nov 6;9(87):35790-35794. doi: 10.18632/oncotarget.26271. eCollection 2018 Nov 6. Review.

18.

Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes.

Tu B, Bi J, Wu D, Zhao P, Shi L, Xie Y, Zhang X, Xu Z, Liu S, Wang X, Li X, Wang F, Qin E.

Oncotarget. 2017 Dec 13;9(87):35780-35789. doi: 10.18632/oncotarget.23200. eCollection 2018 Nov 6.

19.

Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation.

Mahmoud N, Saeed MEM, Sugimoto Y, Klauck SM, Greten HJ, Efferth T.

Oncotarget. 2018 Nov 6;9(87):35762-35779. doi: 10.18632/oncotarget.26299. eCollection 2018 Nov 6.

20.

Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease.

Al-Husein BA, Dawah B, Bani-Hani S, Al Bashir SM, Al-Sawalmeh KM, Ayoub NM.

Oncotarget. 2018 Nov 6;9(87):35752-35761. doi: 10.18632/oncotarget.26293. eCollection 2018 Nov 6.

Supplemental Content

Loading ...
Support Center